Catalase (CAT) is a tetrameric heme-containing enzyme that catalyzes the decomposition of hydrogen peroxide (H₂O₂) to water and oxygen, representing one of the most efficient enzymatic reactions known with a turnover rate exceeding 6 million molecules per second per subunit [1]. In the brain, catalase is primarily localized to peroxisomes in astrocytes and neurons, where it serves as a critical component of antioxidant defense against oxidative stress—a hallmark of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) [2].
| Attribute | Value |
|---|---|
| Protein Name | Catalase |
| Gene Symbol | CAT |
| UniProt ID | P04040 |
| Molecular Weight | ~60 kDa (tetramer, 240 kDa total) |
| Subcellular Localization | Peroxisomes, Cytoplasm |
| Protein Family | Catalase family (EC 1.11.1.6) |
| Chromosome | 11p13 |
| Expression | High in brain (hippocampus, cortex), liver, erythrocytes |
Catalase is a homotetrameric enzyme with each subunit approximately 60 kDa [1:1]. The tetrameric structure provides optimal catalytic efficiency and stability under physiological conditions. Each subunit contains:
The catalytic cycle of catalase involves:
This "ping-pong" mechanism allows catalase to neutralize huge amounts of H₂O₂ efficiently, making it crucial for cellular redox homeostasis.
Catalase is targeted to peroxisomes via:
Catalase's primary function is detoxification of hydrogen peroxide [1:2]:
Catalase is essential for proper peroxisome function:
Catalase expression in the brain shows regional specificity:
| Brain Region | Catalase Expression | Cell Type |
|---|---|---|
| Hippocampus | High (especially CA3) | Astrocytes, Neurons |
| Cerebral Cortex | High (layers II-III, V) | Astrocytes |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Cerebellum | High | Purkinje cells |
| Cerebellar Cortex | Moderate | Granule cells |
Catalase dysfunction is strongly implicated in AD pathogenesis [3][4]:
Catalase plays a particularly important role in PD due to the vulnerability of dopaminergic neurons to oxidative stress [7]:
Catalase involvement in ALS [10]:
Small molecules that mimic catalase activity are being developed [11]:
| Compound | Mechanism | Status |
|---|---|---|
| EUK-8 | Catalase/Superoxide dismutase mimic | Preclinical |
| EUK-134 | Catalase mimic with BBB penetration | Preclinical |
| Tempol | SOD/catalase activity | Research |
Viral vector delivery of catalase shows promise [12]:
Novel delivery methods for catalase [13]:
Catalase functions at the intersection of multiple pathways [2:1]:
Catalase interacts with inflammatory pathways [15]:
Catalase function is regulated by multiple modifications [16]:
| Modification | Effect | Relevance to Disease |
|---|---|---|
| Phosphorylation | Alters activity | Reduced in AD |
| Nitration | Inactivates enzyme | Oxidative stress in PD |
| Acetylation | Affects stability | Aging-related |
| Oxidation | Reduces activity | General oxidative stress |
Catalase as a biomarker:
Catalase in neurodegenerative diseases - new insights into mechanism and therapy. 2024. ↩︎ ↩︎ ↩︎
Oxidative stress in neurodegeneration - role of hydrogen peroxide. 2020. ↩︎ ↩︎
Catalase activity is reduced in Alzheimer's disease brain. 2022. ↩︎
Catalase interactions with amyloid-beta and tau. 2021. ↩︎ ↩︎
Catalase rescues hippocampal memory deficits in a mouse model of AD. 2021. ↩︎
Catalase and Parkinson's disease - protective effects in dopaminergic neurons. 2012. ↩︎
Catalase overexpression protects against alpha-synuclein toxicity. 2023. ↩︎
Catalase mimetics in neurodegenerative disease models. 2022. ↩︎
Catalase gene therapy in animal models of neurodegeneration. 2022. ↩︎
Catalase and neuroinflammation. 2020. ↩︎
Catalase post-translational modifications in aging and AD. 2021. ↩︎